Natixis Takes Position in Mettler-Toledo International Inc. (NYSE:MTD)

Natixis acquired a new position in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,817 shares of the medical instruments supplier's stock, valued at approximately $2,223,000.

Several other hedge funds also recently modified their holdings of the business. Alliancebernstein L.P. boosted its stake in shares of Mettler-Toledo International by 9.9% in the 4th quarter. Alliancebernstein L.P. now owns 583,181 shares of the medical instruments supplier's stock valued at $713,627,000 after purchasing an additional 52,726 shares during the last quarter. Geode Capital Management LLC increased its holdings in Mettler-Toledo International by 2.0% during the 4th quarter. Geode Capital Management LLC now owns 558,471 shares of the medical instruments supplier's stock worth $682,340,000 after purchasing an additional 11,032 shares in the last quarter. Norges Bank bought a new position in Mettler-Toledo International during the 4th quarter worth about $372,954,000. Principal Financial Group Inc. boosted its stake in shares of Mettler-Toledo International by 13.9% during the 4th quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier's stock worth $335,977,000 after buying an additional 33,456 shares during the last quarter. Finally, Barclays PLC boosted its stake in shares of Mettler-Toledo International by 8.3% during the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier's stock worth $384,822,000 after buying an additional 19,609 shares during the last quarter. Institutional investors own 95.07% of the company's stock.

Insider Activity

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the transaction, the insider now owns 6 shares in the company, valued at approximately $8,108.04. This represents a 99.01 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Christian Magloth sold 790 shares of the stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the transaction, the insider now owns 734 shares in the company, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.94% of the company's stock.

Mettler-Toledo International Stock Down 1.2 %

Mettler-Toledo International stock traded down $12.48 during trading hours on Friday, hitting $1,062.52. The stock had a trading volume of 165,723 shares, compared to its average volume of 143,380. The stock has a market cap of $22.14 billion, a price-to-earnings ratio of 26.22, a P/E/G ratio of 3.30 and a beta of 1.28. Mettler-Toledo International Inc. has a one year low of $946.69 and a one year high of $1,546.93. The business's 50 day simple moving average is $1,160.03 and its 200-day simple moving average is $1,243.85.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Research analysts anticipate that Mettler-Toledo International Inc. will post 42.71 EPS for the current fiscal year.

Analyst Ratings Changes

MTD has been the subject of a number of recent research reports. Robert W. Baird reduced their price objective on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research note on Tuesday, April 22nd. Evercore ISI raised their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a research report on Monday, February 10th. Citigroup raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price on the stock in a report on Monday, April 7th. Finally, Wells Fargo & Company lowered their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,125.00 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, Mettler-Toledo International presently has a consensus rating of "Hold" and an average price target of $1,304.25.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.